Działanie Dentoseptu i Dentoseptu A na pałeczki Helicobacter pylori

1. Warren J.R., Marshall B.J.: Unidentified curved bacilli on gastric epithelium in active gastritis. Lancet 1983, 1, 1273. 2. Goodwin C.S., Armstrog J.A., Chilvers T. i wsp.: Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov and Helicobacter mustelae comb. nov respectively. Int. J. Syst. Bacteriol. 1989, 39, 397. 3. Mizoguchi H., Fujioka T., Kisi K. i wsp.: Diversity In protein synthesis and variability of Helicobacter pylori coccoid forms In response to various stimuli. Infect. Immun. 1998, 66, 5555.4. Mach T.: Czy zakażenie Helicobacter pylori jest chorobą odzwierzęcą? Przegl. Lek. 2001, 58, 31. 5. Knigge K.L.: Rola Helicobacter pylori w chorobach układu pokarmowego. Med. Po Dypl. 2002, 11, 79. 6. Łękowska-Kochaniak A.: Mechanizmy patogennego działania Helicobacter pylori. Post. Microbiol. 11994, 33, 447. 7. Buck G.: Campylobacter pylori and gastro-duodenal disease. Clin. Microbiol. Rev. 1990, 3, 1. 8. Oh J.D., Kling-Backned H., Giannakis M. i wsp.: Interactions between gastric epithelial stem cells and atrophic gastritis. Curr. Opin. Microbiol. 2006, 9, 21. 9. Johnes D.M., Lessels A.M., Eldridge J.: Campylobacter like organisms on the gastric mucosa culture, histological, and serological studies. J. Clin. Pathol. 1984, 37, 1002. 10. Price A.B., Levi J.I., Dolby J.M. i wsp.: Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and screening electron microscopy. Gut. 1985, 26, 1183. 11. Lane D.J., Olsen G.J., Pace N.R. i wsp.: Campylobacter pylori, the spiral bacterium associated with human gastritis, is not a true Campylobacter sp. J. Bacteriol., 1987, 169, 2139. 12. Mauch F.G., Bode H., Ditschuneit B.H. i wsp.: Demonstration of phospholipids-rich zone in the human gastric epithelium damage by Helicobacter pylori. Gastroenterol. 1993, 105, 1698. 13. Harris P.R., Mobley H.I., Perez-Perez G.I. i wsp.: Helicobacter pylori urease is a potent stimulus mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterol. 1996, 111, 419. 14. Smith A.W., Chahal B., Freuch G.L.: The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Mol. Microbiol. 1994, 13, 153. 15. Odebriet S., Wieland B., Haas R.: Cloning and genetic characterization of Helicobacter pylori catalase and construction of catalase deficient mutant strain. J. Bacteriol. 1996, 178, 6960. 16. Krajden J., Boccia A., Petreac C. i wsp.: Examination of human stomach biopsies, saliva and dental plaque for Campylobacter pylori. J. Clin. Microbiol. 1989, 27, 1397. 17. Yang H.T.: Nested-polymerase chain reaction in delation of Helicobacter pylori in human dental plaque. Clin. Med. J. 1993, 73, 750. 18. Pytko-Połończyk J., Kaczmarczyk-Stachowska A., Karczewska E. i wsp.: Eradykacja Helicobacter pylori z jamy ustnej i żołądka u pacjentów z chorobą wrzodową. Mag. Stomatol. 1999, 4, 10. 19. Suk F-M., Chen S-H., Ho Y-S. i wsp.: It is difficult to eradicate Helicobacter pylori from dental plaque by triple therapy. Chin. Med. J. 2002, 65, 568. 20. Marzec-Koronczewska Z., Płońska E., Kaczmarek A.: Przewlekłe infekcje zębopochodne, jako czynnik ryzyka chorób układu sercowo-naczyniowego w aspekcie stomatologicznym. Czas. Stomatol. 2001, 54, 249. 21. Ameriso S.F., Fridman E.A., Leiguarda R.C. i wsp.: Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke. 2001, 32, 385. 22. Matilla K.J., Valtonen V.V., Nieminen M.S. i wsp.: Role of infection as a risk factor for atherosclerosis myocardial infarction and stroke. Clin. Infect. Dis. 1998, 26, 719. 23. Miragliotta D., Del Prete R., Mosca A.: Helicobacter pylori infection and coronary heart disease (letter). Lancet 1994, 344, 751. 24. De Luis D., Lahera M., Canton R. i wsp.: Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetes patients. Diabetes Care. 1998, 21, 1129. 25. Pieniążek P., Karczewska E., Duda A. i wsp.: Association of Helicobacter pylori infection with coronary heart disease. J. Physiol. Pharmacol. 1999, 50, 743. 26. O´Gara E.A., Hill D.J., Maslin D.J.: Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl. Environ. Microbiol. 2000, 66, 2269. 27. Canizares P., Gracia I., Gomez L.A. i wsp.: Optimalization of Allium sativum solvent extraction for the inhibition of in vitro growth of Helicobacter pylori. Biotechnol. Prog. 2002, 18, 1227. 28. Sivam G.P.: Protection against Helicobacter pylori and other bacteria infections by Garlic. J. Nutr. 2001, 131, 1106S. 29. Fukai T., Maruno A., Kaitau K. i wsp.: Anti-helicobacter pylori flavonoids from licorice extract. Life Sci. 2002, 71, 1449. 30. Ullman U., Krausse R., Bielenberg J.: Germ-inhibiting effects of glycyrrhetinic acid against Helicobacter pylori. The efficacy of liquorice root in the treatment of stomach ulcers. Arzt. Natur. 2003, 44, 267. 31. Nostro A., Cellini L., Di Bartolomeo S. i wsp.: Antibacterial effect of plant extracts against Helicobacter pylori. Phytother. Res. 2005, 19, 198. 32. Tabak M., Armon R., Potasman I. i wsp.: In vitro inhibition of Helicobacter pylori by extract of thyme. J. Appl. Bacteriol. 1996, 80, 667. 33. Tabak M., Armon R., Neeman I.: Cinnamon extract´s inhibitory effect on Helicobacter pylori. J. Ethnopharmacol. 1999, 67, 267. 34. Wessler A., Geiss H.K., Seller R. i wsp.: A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori. Pharmazie. 2005, 60, 498.35. Ohno T., Kita M., Yamaoka Y. i wsp.: Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter 2003, 8, 207. 36. Preuss H.G., Echard B., Enig M. i wsp.: Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria. Mil. Cell. Bioch. 2005, 272, 2009. 37. Takarada K., Kimizuka R., Takahashi N. i wsp.: Comparison of the antibacterial efficaces of essentials oils against oral pathogenes. Oral Microbiol. Immunol. 2004, 19, 61. 38. Inouye S., Takizawa T., Yamagushi H.: Antibacterial activity of essential oils and their major constituents against respiratory tract pathogens by gaseous contact. J. Antimicrob. Chemother. 2001, 47, 565. 39. Hammer K.A., Carson C.F., Riley T.V.: Microbial activity of essential oils and other plant extracts. J. Appl. Microbiol. 1999, 86, 985. 40. Imai H., Osawa K., Yasuda H. i wsp.: Inhibition by the essential oils of peppermint and spearmint of pathogenic bacteria. Microbios 2001,106 (Suppl. 1), 31. 41. Jonkers D., Slimer J., Stobberingh E.: Effect of garlic on vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 1999, 43, 3045.